Clinical Trial Update: Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 64Cu-SAR-bis-PSMA and 68Ga-PSMA-11 PET CT for detecting recurrence of prostate cancer after radical prostatectomy is ongoing. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 64Cu-SAR-bis-PSMA (64Cu-SAR-bis-PSMA)
• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: St Vincent's Hospital, Sydney | Conditions: Prostate Cancer (Post Prostatectomy) | Phase 2 | Status: RECRUITING